journal article·2016-02-17

Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology

Bina Gidwani, Amber Vyas

Publisher page

Abstract

The objective of the present study was to prepare solid lipid nanoparticles (SLNs) of altretamine (ALT) by the hot homogenization and ultrasonication method. The study was conducted using the Box-Behnken design (BBD), with a 3(3) design and a total of 17 experimental runs, performed in combination with response surface methodology (RSM). The SLNs were evaluated for mean particle size, entrapment efficiency, and drug-loading. The optimized formulation, with a desirability factor of 0.92, was selected and characterized. In vitro release studies showed a biphasic release pattern from the SLNs for up to 24 h. The results of % EE (93.21 ± 1.5), %DL (1.15 ± 0.6), and mean diameter of (100.6 ± 2.1) nm, were very close to the predicted values.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior · Essential Oils and Antimicrobial Activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University Institute of Pharmacy, Pt. Ravi Shankar Shukla University, Raipur, Chhattisgarh, India

References (35)

Show source-provided references
1. 10.1016/j.ejps.2010.10.00210.1016/j.ejps.2010.10.002 ↗
2. 10.1023/A:101621280428810.1023/A:1016212804288 ↗
3. 10.1016/S0928-0987(01)00095-110.1016/S0928-0987(01)00095-1 ↗
4. 10.2165/00003088-199528060-0000210.2165/00003088-199528060-00002 ↗
5. 10.1016/j.colsurfb.2011.07.03610.1016/j.colsurfb.2011.07.036 ↗
6. Dash S · Acta Pol Pharm · 2010 · 67 · 217
7. 10.1016/S0928-0987(02)00051-910.1016/S0928-0987(02)00051-9 ↗
8. 10.33786/JCPR.2011.v01i02.01210.33786/JCPR.2011.v01i02.012 ↗
9. 10.1186/2008-2231-21-6810.1186/2008-2231-21-68 ↗
10. 10.1016/j.colsurfb.2013.09.03510.1016/j.colsurfb.2013.09.035 ↗
11. Gidwani B · Artif Cells Nanomed Biotech · 2013 · 1
12. 10.1177/10600280910250020910.1177/106002809102500209 ↗
13. 10.1080/0265204011008139810.1080/02652040110081398 ↗
14. Higuchi T. · Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci · 1963 · 52 · 1145
15. Khan AA · Int J Nanomed · 2013 · 8 · 2733
16. 10.1002/jps.260064112210.1002/jps.2600641122 ↗
17. 10.1016/S0378-5173(99)00422-610.1016/S0378-5173(99)00422-6 ↗
18. Lewis GA · 1999 · 92
19. 10.1016/j.colsurfa.2009.11.00610.1016/j.colsurfa.2009.11.006 ↗
20. 10.1002/ejlt.20070019610.1002/ejlt.200700196 ↗
21. 10.2174/15701631179679906210.2174/157016311796799062 ↗
22. 10.1016/j.nano.2008.08.00310.1016/j.nano.2008.08.003 ↗
23. 10.1016/S0169-409X(01)00182-X10.1016/S0169-409X(01)00182-X ↗
24. 10.1016/j.ejpb.2010.05.00310.1016/j.ejpb.2010.05.003 ↗
25. 10.1016/j.colsurfb.2012.04.02710.1016/j.colsurfb.2012.04.027 ↗
26. 10.3923/ajdd.2011.174.18710.3923/ajdd.2011.174.187 ↗
27. 10.1016/j.colsurfa.2005.10.06410.1016/j.colsurfa.2005.10.064 ↗
28. 10.3109/1071754100366776410.3109/10717541003667764 ↗
29. 10.1002/1097-0142(19901015)60:8+<2104::AID-CNCR2820601524>3.0.CO;2-D10.1002/1097-0142(19901015)60:8+<2104::AID-CNCR2820601524>3.0.CO;2-D ↗
30. 10.1016/j.jconrel.2004.01.00510.1016/j.jconrel.2004.01.005 ↗
31. 10.3109/0735790920903278310.3109/07357909209032783 ↗
32. 10.1016/S0169-409X(01)00105-310.1016/S0169-409X(01)00105-3 ↗
33. 10.1016/j.addr.2007.04.00810.1016/j.addr.2007.04.008 ↗
34. 10.1002/jps.2154910.1002/jps.21549 ↗
35. 10.1016/j.powtec.2009.09.00410.1016/j.powtec.2009.09.004 ↗